Group 1 - The S&P 500 achieved its seventh consecutive monthly gain in November, with a 0.4% increase, contributing to an overall year-to-date rise of 16.5% [3][10] - An investment of $10,000 in the top-performing S&P 500 stock each month since January would have grown to $392,513, reflecting an extraordinary 3,825% gain over 11 months [2][3] - Albemarle emerged as the top stock in November, rising 32.8%, marking its second time as the monthly leader this year [6][7] Group 2 - Analysts project Albemarle's earnings per share to increase by 63% in 2025 and by 205% in 2026, although the stock is currently considered extended beyond its 200-day moving average [7][8] - Other notable performers in November included Eli Lilly, which gained 27%, and Solventum, which rose 23% [8] - Historically, December is the third-best month for S&P 500 performance, with an average gain of 1.4%, but there are concerns about potential market corrections due to high valuations and external risks [9][10]
11 Stocks Turn $10,000 Into $392,513 In 11 Months